• Profile

Diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis

Alimentary Pharmacology and Therapeutics Evidence based | Aug 11, 2017

Zagari RM, et al. – This meta–analysis aspired to evaluate the diagnostic performance of the serum panel test for the diagnosis of atrophic gastritis. For the diagnosis of atrophic gastritis, the combination of pepsinogen, gastrin–17, and anti–H. pylori antibodies serological assays appeared to be a reliable tool. For screening subjects or populations at high risk of gastric cancer for atrophic gastritis, this test could be used. However, a cost–effectiveness analysis was required.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen